Stories
Don't sit that long - it increases your cancer risk
Sorry, I couldn't resist. This article says that in a study, women who sat more than 6 hours a day were at a higher risk of developing breast cancer, ovarian c...
Don't sit that long - it increases your cancer risk
Sorry, I couldn't resist. This article says that in a study, women who sat more than 6 hours a day were at a higher risk of developing breast cancer, ovarian c...
STORIES
New to Care Across? Sign up to read all comments and join the conversation
Answers
ANSWERS
You are only a click away from reading the answer. Simply join or Sign in.
News
>
Latest research available at a glance
Multiple myeloma treatment expected to be approved in Europe
European regulators have adopted a positive opinion for ixazomib capsules combined with lenalidomide and dexamethasone for the treatment of multiple myeloma.
Mantle cell lymphoma: lenalidomide gets EU approval
REVLIMID® (lenalidomide) received approval by the European Commission for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.